These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5132121)

  • 1. Subcellular distribution of 8- 14 C-mescaline in the mouse brain and liver.
    Shah NS
    Biochem Pharmacol; 1971 Nov; 20(11):3207-10. PubMed ID: 5132121
    [No Abstract]   [Full Text] [Related]  

  • 2. Study with mescaline-8-C14 in mice: effect of amine oxidase inhibitors on metabolism.
    Shah NS; Himwich HE
    Neuropharmacology; 1971 Sep; 10(5):547-56. PubMed ID: 5126692
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain levels of serotonin (5-HT) and norepinephrine (NE) during mescaline-induced behavior in mice.
    Shah NS
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):201-4. PubMed ID: 4686103
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.
    Shah NS
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):357-61. PubMed ID: 5119220
    [No Abstract]   [Full Text] [Related]  

  • 5. Placental transfer and tissue distribution of mescaline- 14 C in the mouse.
    Shah NS; Neely AE; Shah KR; Lawrence RS
    J Pharmacol Exp Ther; 1973 Feb; 184(2):489-93. PubMed ID: 4688184
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of chlorpromazine and haloperidol on the disposition of mescaline-14C in mice.
    Shah NS; Shah KR; Lawrence RS; Neely AE
    J Pharmacol Exp Ther; 1973 Aug; 186(2):297-304. PubMed ID: 4719782
    [No Abstract]   [Full Text] [Related]  

  • 7. Alteration by pretreatment with iproniazid and an inactive mescaline analogue of a behaviour change induced by mescaline.
    Smythies JR; Johnston VS; Bradley RJ
    Nature; 1967 Oct; 216(5111):196-7. PubMed ID: 6057240
    [No Abstract]   [Full Text] [Related]  

  • 8. The metabolism of mescaline-14-C in rats.
    Musacchio JM; Goldstein M
    Biochem Pharmacol; 1967 Jun; 16(6):963-70. PubMed ID: 6040403
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional localization of 3,4-dimethoxyphenylethylamine- 14 C (DMPEA- 14 C) in rabbit brain: effects of reserpine and iproniazid pretreatment.
    Shah NS; Alpers HS; Himwich HE
    J Pharmacol Exp Ther; 1972 Jan; 180(1):144-50. PubMed ID: 5010411
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug interaction--effect of chlorpromazine on the disposition of 8- 14 C-mescaline in fetal and maternal brain and liver in pregnant mouse.
    Shah NS; Neely AE
    Biochem Pharmacol; 1973 Jun; 22(12):1535-8. PubMed ID: 4732531
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of diphenylhydantoin-4- 14 C with subcellular fractions of rat brain.
    Wilensky AJ; Lowden JA
    Can J Physiol Pharmacol; 1972 Apr; 50(4):346-53. PubMed ID: 5038352
    [No Abstract]   [Full Text] [Related]  

  • 12. Placental transfer and fetal distribution of mescaline- 14 C in monkeys.
    Taska RJ; Schoolar JC
    J Pharmacol Exp Ther; 1972 Nov; 183(2):427-32. PubMed ID: 4628416
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of psychotropic drugs and beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in mice.
    Shah NS
    Biochem Pharmacol; 1976 Mar; 25(5):591-7. PubMed ID: 8055
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of mescaline and 2,5-dimethoxy-4-methylphenethylamine on sleeping time in mice.
    Ho BT; Huang JT
    J Pharm Pharmacol; 1970 Dec; 22(12):949-51. PubMed ID: 4395524
    [No Abstract]   [Full Text] [Related]  

  • 15. Discriminative stimulus properties of mescaline: mescaline or metabolite?
    Browne RG; Ho BT
    Pharmacol Biochem Behav; 1975; 3(1):109-14. PubMed ID: 1129346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of neuropharmacological agents on metabolism in vitamin B6 in brain.
    McCoy EE; Henn SW; Colombini CE
    Adv Biochem Psychopharmacol; 1972; 4():93-104. PubMed ID: 4557808
    [No Abstract]   [Full Text] [Related]  

  • 17. Central nervous system effects of fenfluramine hydrochloride.
    Ziance RJ; Sipes IG; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of factors changing catecholamine metabolism on the dynamics of nonesterified fatty acids in the liver and blood].
    Menisov AK
    Probl Endokrinol (Mosk); 1973; 19(1):84-6. PubMed ID: 4698466
    [No Abstract]   [Full Text] [Related]  

  • 19. Some neurochemical and neuropharmacological studies on the interactions between mescaline and 1-methyl-1,2,5,6-tetrahydropyridine-3-(N,N-diethylcarboxamide) (THPC).
    Leonard BE; Stonier PD
    Psychopharmacologia; 1972; 25(1):1-13. PubMed ID: 5038979
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of chronic treatment with mescaline upon tissue levels of the drug.
    Sethy VH; Winter JC
    Experientia; 1973 May; 29(5):571-2. PubMed ID: 4730293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.